Q4 2021 Ligand Pharmaceuticals Inc Earnings Call Transcript
Good day and thank you for standing by and welcome to the Ligand Pharmaceuticals Q4 Earnings Call. (Operator Instructions) Please be advised that this call is being recorded (Operator Instructions)
I would now like to hand the conference over to your host today, Simon Latimer, Head of Investor Relations. You may begin.
Thank you, Justin. Welcome to Ligand's Fourth Quarter of 2021 Financial Results and Business Update Conference Call. Our speakers for today's call are in separate locations. Speaking today for Ligand will be John Higgins, CEO; Matt Foehr, COO; and Matt Korenberg, CFO.
We will use non-GAAP financial measures and some of our statements will be forward-looking, including those related to our financial condition, results of operations, financial guidance and the impact of the COVID-19 pandemic and plans for OmniAb to become a standalone public company. Additional information concerning risk factors and other matters concerning Ligand can be found in our earnings press release and our periodic filings with the SEC. We
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |